Workflow
SunCoke Energy(SXC) - 2024 Q3 - Quarterly Report

Financial Performance - Net income for Q3 2024 was 33.3million,asignificantincreaseof29233.3 million, a significant increase of 292% compared to 8.5 million in Q3 2023[72] - Adjusted EBITDA for Q3 2024 was 75.3million,up15.175.3 million, up 15.1% from 65.4 million in Q3 2023[72] - Revenues for Q3 2024 decreased to 490.1million,down5.8490.1 million, down 5.8% from 520.4 million in Q3 2023[76] - Domestic Coke sales for the three months ended September 30, 2024, were 459.9million,adecreaseof459.9 million, a decrease of 35.8 million (7.2%) compared to 495.7millionintheprioryear[82]AdjustedEBITDAforDomesticCokeinthesameperiodwas495.7 million in the prior year[82] - Adjusted EBITDA for Domestic Coke in the same period was 58.1 million, down 5.9million(9.25.9 million (9.2%) from 64.0 million in the prior year[82] - Total sales and other operating revenues for the company were 490.1millionforthethreemonthsendedSeptember30,2024,adecreaseof490.1 million for the three months ended September 30, 2024, a decrease of 30.3 million (5.8%) from 520.4millionintheprioryear[82]OperatingincomeforQ32024was520.4 million in the prior year[82] - Operating income for Q3 2024 was 47.2 million, up from 29.7millioninQ32023,reflectingagrowthof58.529.7 million in Q3 2023, reflecting a growth of 58.5%[8] - Basic earnings per share for Q3 2024 were 0.36, compared to 0.08inQ32023,markinga3500.08 in Q3 2023, marking a 350% increase[8] Cash Flow and Capital Expenditures - Net cash provided by operating activities decreased by 84.7 million to 107.9millionfortheninemonthsendedSeptember30,2024,comparedto107.9 million for the nine months ended September 30, 2024, compared to 192.6 million in the prior year[94] - Net cash used in investing activities decreased by 37.8millionto37.8 million to 47.6 million for the nine months ended September 30, 2024, primarily due to the absence of capital spending on specific projects[95] - Net cash used in financing activities decreased by 35.6millionto35.6 million to 35.7 million for the nine months ended September 30, 2024, driven by lower net repayments on the Revolving Facility[96] - Total capital expenditures for the nine months ended September 30, 2024, were 48.1million,downfrom48.1 million, down from 84.5 million in the prior year[100] - Ongoing capital expenditures were 44.1millionfortheninemonthsendedSeptember30,2024,comparedto44.1 million for the nine months ended September 30, 2024, compared to 73.2 million in the prior year[100] - Future capital expenditures are projected to be around 50million,aimedatupgradingexistingfacilities[6]DebtandComplianceThecompanywasincompliancewithallapplicabledebtcovenantsasofSeptember30,2024,anddoesnotanticipateanyviolations[97]TotaldebtasofSeptember30,2024,was50 million, aimed at upgrading existing facilities[6] Debt and Compliance - The company was in compliance with all applicable debt covenants as of September 30, 2024, and does not anticipate any violations[97] - Total debt as of September 30, 2024, was 491.8 million, slightly up from 490.3millionasofDecember31,2023[31]TheCompanyhad490.3 million as of December 31, 2023[31] - The Company had 350.0 million available under its revolving credit facility as of September 30, 2024, with no outstanding balance[32] Operational Highlights - Domestic coke plants operated at full capacity during the nine months ended September 30, 2024, with long-term agreements insulating them from global price fluctuations[70] - The logistics segment saw higher transloading volumes and pricing, contributing to improved financial performance[72] - The company operates five cokemaking facilities in the U.S. with a total capacity of approximately 4.2 million tons per year[69] - Tons handled in the Logistics segment increased to 5,843 thousand tons for the three months ended September 30, 2024, up 882 thousand tons (17.7%) from 4,961 thousand tons in the prior year[82] Black Lung Liabilities - The company recognized a 9.5millionpretaxgainfromextinguishingcertainblacklungliabilities,reducingtheliabilityby9.5 million pre-tax gain from extinguishing certain black lung liabilities, reducing the liability by 45.5 million[74] - As of September 30, 2024, the total black lung liability, discounted, is 14.4million,downfrom14.4 million, down from 58.2 million as of December 31, 2023, reflecting a reduction of 45.5millionduetoaregulatoryexemptionagreement[36]Thecompanymadealumpsumpaymentof45.5 million due to a regulatory exemption agreement[36] - The company made a lump sum payment of 36.0 million to satisfy its self-insured federal black lung liabilities on August 13, 2024[91] Market and Strategic Initiatives - The company provided an optimistic outlook, projecting a revenue growth of 10-12% for the next quarter[7] - New product launches are expected to contribute an additional 30millioninrevenueoverthenextfiscalyear[6]ThecompanyisexpandingitsmarketpresenceinAsia,targetinga2530 million in revenue over the next fiscal year[6] - The company is expanding its market presence in Asia, targeting a 25% increase in market share by the end of the year[7] - A strategic acquisition of a logistics firm was completed, expected to enhance operational efficiency and reduce costs by 15%[6] Shareholder Returns - The company declared a cash dividend of 0.12 per share on July 31, 2024, and another on October 31, 2024, to be paid on December 2, 2024[97] - Dividends paid in Q3 2024 amounted to 27.5million,anincreasefrom27.5 million, an increase from 22.3 million in Q3 2023[15] Other Financial Metrics - Total assets as of September 30, 2024, were 1,654.8million,slightlydownfrom1,654.8 million, slightly down from 1,660.4 million at the end of 2023[13] - Cash and cash equivalents increased to 164.7millionfrom164.7 million from 140.1 million at the end of 2023, showing a growth of 17.5%[13] - Total liabilities decreased to 963.8millionfrom963.8 million from 1,014.9 million at the end of 2023, a reduction of 5.0%[13] - The effective tax rate for the three months ended September 30, 2024, was 19.8%, significantly lower than 63.2% for the same period in 2023[28]